Gross Profit On Sales Veränderung Datum
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Amgen USD 5.08B 14M 2023-12
Astellas Pharma JPY 317.74B 11.69B 2023-09
Bayer EUR 5.53B 796M 2023-09
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Daiichi Sankyo JPY 280.77B 23.61B 2023-09
Eisai JPY 140.19B 12.82B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Exelixis USD 453.15M 1M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Incyte USD 949.29M 84.66M 2023-12
Insmed USD 65.25M 2.88M 2023-12
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Takeda JPY 699.51B 38B 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Seattle Genetics Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.